Acute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (Unesp)-
Autor(es): dc.contributorClínica Ricardo Palma-
Autor(es): dc.contributorUniversidad Nacional Del Noroeste de Buenos Aires-
Autor(es): dc.contributorKarolinska Institutet-
Autor(es): dc.creatorPonce, Daniela [UNESP]-
Autor(es): dc.creatorBalbi, André L [UNESP]-
Autor(es): dc.creatorDurand, Jonathan B-
Autor(es): dc.creatorMoretta, Gustavo-
Autor(es): dc.creatorDivino-Filho, José C-
Data de aceite: dc.date.accessioned2022-02-22T00:44:01Z-
Data de disponibilização: dc.date.available2022-02-22T00:44:01Z-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2020-06-01-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1093/ckj/sfaa102-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/205318-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/205318-
Descrição: dc.descriptionThe kidney is not typically the main target of severe acute respiratory syndrome coronavirus 2, but surprisingly, acute kidney injury (AKI) may occur in 4-23% of cases, whereas the dialysis management of AKI from coronavirus 2019 has not gained much attention. The severity of the pandemic has resulted in significant shortages in medical supplies, including respirators, ventilators and personal protective equipment. Peritoneal dialysis (PD) remains available and has been used in clinical practice for AKI for >70 years; however, it has been used on only a limited basis and therefore experience and knowledge of its use has gradually vanished, leaving a considerable gap. The turning point came in 2007, with a series of sequential publications providing solid evidence that PD is a viable option. As there was an availability constraint and a capacity limit of equipment/supplies in many countries, hemodialysis and convective therapies became alternatives. However, even these therapies are not available in many countries and their capacity is being pushed to the limit in many cities. Evidence-based PD experience lends support for the use of PD now.-
Descrição: dc.descriptionInternal Medicine Department University of Sao Paulo State UNESP-
Descrição: dc.descriptionNephrology Department Universidad Cientifica Del sur S.a.c Clínica Ricardo Palma-
Descrição: dc.descriptionNephrology Department Universidad Nacional Del Noroeste de Buenos Aires-
Descrição: dc.descriptionDivision of Renal Medicine CLINTEC Karolinska Institutet Campus Flemingsberg-
Descrição: dc.descriptionInternal Medicine Department University of Sao Paulo State UNESP-
Formato: dc.format269-273-
Idioma: dc.languageen-
Relação: dc.relationClinical Kidney Journal-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectacute kidney injury-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectcytokines-
Palavras-chave: dc.subjectmortality-
Palavras-chave: dc.subjectperitoneal dialysis-
Título: dc.titleAcute peritoneal dialysis in the treatment of COVID-19-related acute kidney injury-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.